Cargando…

The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities

SIMPLE SUMMARY: Multiple myeloma (MM) is an aggressive hematological neoplasia caused by the uncontrolled proliferation of aberrant plasmacells. Neoplastic transformation and progression are driven by a number of biological processes, called ‘hallmarks of cancer’, which are regulated by different mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saltarella, Ilaria, Apollonio, Benedetta, Lamanuzzi, Aurelia, Desantis, Vanessa, Mariggiò, Maria Addolorata, Desaphy, Jean-François, Vacca, Angelo, Frassanito, Maria Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032822/ https://www.ncbi.nlm.nih.gov/pubmed/35454868 http://dx.doi.org/10.3390/cancers14081963

Ejemplares similares

Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives
por: Saltarella, Ilaria, et al.
Publicado: (2022)

Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma Progression
por: Saltarella, Ilaria, et al.
Publicado: (2021)

Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2020)

Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications
por: Lamanuzzi, Aurelia, et al.
Publicado: (2023)

MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
por: Desantis, Vanessa, et al.
Publicado: (2020)

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance
por: Melaccio, Assunta, et al.
Publicado: (2022)

Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
por: Desantis, V., et al.
Publicado: (2018)

Anti-Angiogenic Activity of Drugs in Multiple Myeloma
por: Saltarella, Ilaria, et al.
Publicado: (2023)

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?()
por: Saltarella, Ilaria, et al.
Publicado: (2018)

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
por: Lamanuzzi, Aurelia, et al.
Publicado: (2018)

MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease
por: Desantis, Vanessa, et al.
Publicado: (2021)

Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
por: Reale, Antonia, et al.
Publicado: (2016)

Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients
por: Lamanuzzi, Aurelia, et al.
Publicado: (2016)

Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis
por: Cicco, Sebastiano, et al.
Publicado: (2022)

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin(®) protein MP0250: a preclinical study
por: Rao, Luigia, et al.
Publicado: (2018)

Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging
por: Grammatikakis, Ioannis, et al.
Publicado: (2014)

The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value
por: Desantis, Vanessa, et al.
Publicado: (2022)

Microenvironment drug resistance in multiple myeloma: emerging new players
por: Di Marzo, Lucia, et al.
Publicado: (2016)

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
por: Carrasco-Leon, Arantxa, et al.
Publicado: (2021)

A pan‐cancer atlas of cancer hallmark‐associated candidate driver lncRNAs
por: Deng, Yulan, et al.
Publicado: (2018)

High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
por: Solimando, Antonio Giovanni, et al.
Publicado: (2019)

The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
por: Salamini-Montemurri, Martín, et al.
Publicado: (2020)

The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma
por: Carrasco-León, Arantxa, et al.
Publicado: (2021)

Editorial: Hallmark of cancer: avoiding immune suppression
por: Alenzi, Faris Q. B., et al.
Publicado: (2023)

LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022)

Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib
por: Tang, Ju‐xian, et al.
Publicado: (2021)

Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma
por: Ria, Roberto, et al.
Publicado: (2016)

Transcriptomic landscape of lncRNAs in inflammatory bowel disease
por: Mirza, Aashiq H, et al.
Publicado: (2015)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma
por: Paul, Yashna, et al.
Publicado: (2018)

Functions and properties of nuclear lncRNAs—from systematically mapping the interactomes of lncRNAs
por: Guh, Chia-Yu, et al.
Publicado: (2020)

LncRNAs Landscape in the patients of primary gout by microarray analysis
por: Qing, Yu-Feng, et al.
Publicado: (2021)

The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective
por: Unfried, Juan Pablo, et al.
Publicado: (2021)

Circulating LncRNAs landscape as potential biomarkers in breast cancer
por: Pourramezan, Zahra, et al.
Publicado: (2022)

Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma
por: Ismail, Nor Hayati, et al.
Publicado: (2023)

LncRNAs in Stem Cells
por: Hu, Shanshan, et al.
Publicado: (2016)

LncRNAs in pancreatic cancer
por: Huang, Xiaoyi, et al.
Publicado: (2016)

The Role of LncRNAs in Translation
por: Karakas, Didem, et al.
Publicado: (2021)

Perspectives of LncRNAs for therapy
por: Ilieva, Mirolyuba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6pt0059e4ufuep0a1chd6ar20u